Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 6 | 2026 | 97 | 2.210 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2019 | 65 | 1.790 |
Why?
|
| Humanities | 2 | 2022 | 2 | 1.490 |
Why?
|
| Curriculum | 2 | 2022 | 203 | 1.310 |
Why?
|
| Hip Prosthesis | 5 | 2019 | 23 | 1.050 |
Why?
|
| Femur | 4 | 2022 | 75 | 0.900 |
Why?
|
| Postoperative Complications | 3 | 2025 | 823 | 0.810 |
Why?
|
| Gastroparesis | 1 | 2023 | 10 | 0.800 |
Why?
|
| Orthopedics | 2 | 2021 | 93 | 0.730 |
Why?
|
| Fractures, Stress | 1 | 2022 | 10 | 0.700 |
Why?
|
| Tibial Fractures | 1 | 2022 | 30 | 0.700 |
Why?
|
| Arthritis | 1 | 2022 | 30 | 0.700 |
Why?
|
| Intraoperative Care | 2 | 2019 | 52 | 0.680 |
Why?
|
| Noise, Occupational | 1 | 2020 | 2 | 0.630 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2020 | 3 | 0.630 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 6 | 0.600 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 19 | 0.600 |
Why?
|
| Pubic Symphysis | 1 | 2018 | 3 | 0.570 |
Why?
|
| Sacroiliac Joint | 1 | 2018 | 12 | 0.560 |
Why?
|
| Pelvic Bones | 1 | 2018 | 30 | 0.550 |
Why?
|
| Histology | 1 | 2017 | 5 | 0.540 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 106 | 0.520 |
Why?
|
| Health Care Costs | 1 | 2017 | 122 | 0.490 |
Why?
|
| Knee Joint | 1 | 2017 | 128 | 0.490 |
Why?
|
| Hand | 2 | 2026 | 81 | 0.480 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 199 | 0.480 |
Why?
|
| Humans | 22 | 2026 | 32284 | 0.450 |
Why?
|
| Osteoarthritis, Knee | 2 | 2026 | 71 | 0.440 |
Why?
|
| Hip Joint | 2 | 2014 | 68 | 0.370 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2011 | 65 | 0.360 |
Why?
|
| Femur Neck | 1 | 2011 | 18 | 0.340 |
Why?
|
| Femur Head | 1 | 2011 | 12 | 0.340 |
Why?
|
| Ossification, Heterotopic | 1 | 2011 | 21 | 0.330 |
Why?
|
| Retrospective Studies | 8 | 2026 | 3628 | 0.320 |
Why?
|
| Joint Diseases | 1 | 2009 | 31 | 0.280 |
Why?
|
| Tendinopathy | 1 | 2007 | 12 | 0.270 |
Why?
|
| Tendons | 1 | 2007 | 50 | 0.260 |
Why?
|
| Calcinosis | 1 | 2007 | 143 | 0.250 |
Why?
|
| Clinical Competence | 1 | 2009 | 330 | 0.240 |
Why?
|
| Functional Laterality | 1 | 2026 | 64 | 0.230 |
Why?
|
| Leg | 1 | 2026 | 69 | 0.230 |
Why?
|
| Aged | 6 | 2026 | 10265 | 0.220 |
Why?
|
| Adult | 5 | 2020 | 9259 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 13 | 0.200 |
Why?
|
| Male | 9 | 2026 | 19443 | 0.200 |
Why?
|
| Fasting | 1 | 2023 | 88 | 0.200 |
Why?
|
| Female | 9 | 2026 | 19947 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 520 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2026 | 3902 | 0.190 |
Why?
|
| Young Adult | 4 | 2017 | 2649 | 0.190 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 31 | 0.190 |
Why?
|
| Tibia | 1 | 2022 | 56 | 0.170 |
Why?
|
| Gloves, Surgical | 1 | 2021 | 2 | 0.170 |
Why?
|
| Protective Clothing | 1 | 2021 | 21 | 0.170 |
Why?
|
| North Carolina | 2 | 2022 | 1300 | 0.160 |
Why?
|
| Middle Aged | 5 | 2026 | 11853 | 0.150 |
Why?
|
| Arthroplasty | 1 | 2019 | 28 | 0.150 |
Why?
|
| Radiography | 2 | 2011 | 363 | 0.140 |
Why?
|
| Rotation | 1 | 2018 | 51 | 0.140 |
Why?
|
| Cadaver | 1 | 2018 | 151 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2017 | 73 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2025 | 3416 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 553 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 30 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 17 | 0.100 |
Why?
|
| HMGB1 Protein | 1 | 2013 | 11 | 0.100 |
Why?
|
| Brain Edema | 1 | 2013 | 16 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 46 | 0.100 |
Why?
|
| Cachexia | 1 | 2013 | 7 | 0.100 |
Why?
|
| Evidence-Based Nursing | 1 | 2013 | 4 | 0.100 |
Why?
|
| Microglia | 1 | 2013 | 67 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2013 | 75 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 91 | 0.090 |
Why?
|
| Incidence | 2 | 2016 | 1241 | 0.090 |
Why?
|
| Neurons | 1 | 2013 | 486 | 0.080 |
Why?
|
| Arthroscopy | 1 | 2011 | 242 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2009 | 107 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 534 | 0.070 |
Why?
|
| Risk Factors | 2 | 2016 | 3934 | 0.070 |
Why?
|
| Splints | 1 | 2007 | 13 | 0.070 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 11 | 0.060 |
Why?
|
| Bone Cements | 1 | 2007 | 10 | 0.060 |
Why?
|
| Knee Prosthesis | 1 | 2007 | 18 | 0.060 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 85 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2009 | 854 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2007 | 146 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 907 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 2240 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 324 | 0.050 |
Why?
|
| Range of Motion, Articular | 1 | 2025 | 196 | 0.050 |
Why?
|
| Sex Factors | 1 | 2026 | 657 | 0.050 |
Why?
|
| Time Factors | 1 | 2009 | 2205 | 0.050 |
Why?
|
| Comorbidity | 1 | 2025 | 565 | 0.050 |
Why?
|
| United States | 1 | 2011 | 4072 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 94 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 757 | 0.040 |
Why?
|
| Osteotomy | 1 | 2019 | 55 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2016 | 77 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 2016 | 25 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 135 | 0.030 |
Why?
|
| Oxazoles | 1 | 2013 | 7 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 36 | 0.030 |
Why?
|
| Acetates | 1 | 2013 | 14 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2013 | 28 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2013 | 53 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2014 | 125 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 143 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 236 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 717 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 839 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 478 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 893 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2013 | 276 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1083 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 2571 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 964 | 0.020 |
Why?
|
| Equipment Design | 1 | 2007 | 178 | 0.020 |
Why?
|
| Adolescent | 1 | 2011 | 3519 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 8199 | 0.010 |
Why?
|